Nimodipine/Strong CYP3A4 Inhibitors Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
Some medicines may slow down how quickly your body processes nimodipine.
What might happen:
The amount of nimodipine in your blood may increase and cause side effects.
What you should do about this interaction:
Let your healthcare professionals know that you are taking these medicines together. Your doctor may want to change the dose of your medicine.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
- 1.Nimodipine capsule US prescribing information. BIONPHARMA INC. January, 2020.
- 2.Nymalize (nimodipine) solution US prescribing information. Arbor Pharmaceuticals April, 2020.
- 3.Nimotop (nimodipine) Canadian prescribing information. Bayer Inc. November 2011.
- 4.Tybost (cobicistat) US prescribing information. Gilead Sciences, Inc. August, 2020.
- 5.Norvir (ritonavir) US prescribing information. Abbott Laboratories December, 2019.
- 6.Muck W, Wingender W, Seiberling M, Woelke E, Ramsch KD, Kuhlmann J. Influence of the H2-receptor antagonists cimetidine and ranitidine on the pharmacokinetics of nimodipine in healthy volunteers. Eur J Clin Pharmacol 1992;42(3):325-8.
- 7.US Food and Drug Administration (FDA). Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. Available at: https://www.fda.gov/drugs/drug-interactions-labeling/drug-development-and- drug-interactions-table-substrates-inhibitors-and-inducers. Updated 11/14/2017.
- 8.This information is based on or an extract from the UW Metabolism and Transport Drug Interaction Database (DIDB) Platform, Copyright University of Washington 1999-2019..
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.